OBJECTIVE: To identify the magnitude of ocular complications in HIV infection in Chiang Mai, and determine the signs or symptoms that indicate the risk factors for developing ocular complications in HIV-positive patients METHOD: A prospective study was carried out in newly diagnosed HIV-positive patients seen in the Ocular Infectious Disease Clinic of Maharaj Nakorn Chiang Mai Hospital from March 1, 2000 through February 28, 2001. A complete ophthalmic examination was performed on each patient together with a systemic evaluation of present illness and current medications. RESULTS: Three-hundred and ninety-five HIV-positive patients were seen for ophthalmic evaluation. Of these, 90 were in stage A (asymptomatic), 84 were in stage B (symptomatic), and 221 were in stage C (AIDS). Ocular complications were found in 44.6 per cent of the patients. Cytomegalovirus (CMV) retinitis was the most common ophthalmic complication (33%). Other ocular complications included cotton wool spot (8%), uveitis (4%), optic neuropathy (3%), and keratoconjunctivitis sicca (2%). The clinical presenting symptoms, which were the indicators for ocular complications and CMV retinitis, included chronic cough, oral thrush, chronic diarrhea, weight loss, wasting, and skin disorders. Ocular symptoms, which indicated a high risk of developing CMV retinitis, included flashing, floaters, and scotoma. CONCLUSIONS: Ocular complications are common in HIV-positive patients. CMV retinitis, which is a major vision-threatening problem, represented the most common finding. It is recommended that HIV-positive patients should have their eyes examined regularly, particularly when they have the clinical presenting symptoms previously mentioned. The patients should also notice early symptoms of CMV retinitis, which includes flashing, floaters, and scotoma.
OBJECTIVE: To identify the magnitude of ocular complications in HIV infection in Chiang Mai, and determine the signs or symptoms that indicate the risk factors for developing ocular complications in HIV-positivepatients METHOD: A prospective study was carried out in newly diagnosed HIV-positivepatients seen in the Ocular Infectious Disease Clinic of Maharaj Nakorn Chiang Mai Hospital from March 1, 2000 through February 28, 2001. A complete ophthalmic examination was performed on each patient together with a systemic evaluation of present illness and current medications. RESULTS: Three-hundred and ninety-five HIV-positivepatients were seen for ophthalmic evaluation. Of these, 90 were in stage A (asymptomatic), 84 were in stage B (symptomatic), and 221 were in stage C (AIDS). Ocular complications were found in 44.6 per cent of the patients. Cytomegalovirus (CMV) retinitis was the most common ophthalmic complication (33%). Other ocular complications included cotton wool spot (8%), uveitis (4%), optic neuropathy (3%), and keratoconjunctivitis sicca (2%). The clinical presenting symptoms, which were the indicators for ocular complications and CMV retinitis, included chronic cough, oral thrush, chronic diarrhea, weight loss, wasting, and skin disorders. Ocular symptoms, which indicated a high risk of developing CMV retinitis, included flashing, floaters, and scotoma. CONCLUSIONS:Ocular complications are common in HIV-positivepatients. CMV retinitis, which is a major vision-threatening problem, represented the most common finding. It is recommended that HIV-positivepatients should have their eyes examined regularly, particularly when they have the clinical presenting symptoms previously mentioned. The patients should also notice early symptoms of CMV retinitis, which includes flashing, floaters, and scotoma.
Authors: Jenny Chen; Somsanguan Ausayakhun; Sakarin Ausayakhun; Choeng Jirawison; Claire M Khouri; Travis C Porco; David Heiden; Jeremy D Keenan; Todd P Margolis Journal: Invest Ophthalmol Vis Sci Date: 2011-12-09 Impact factor: 4.799
Authors: Somsanguan Ausayakhun; Jeremy D Keenan; Sakarin Ausayakhun; Choeng Jirawison; Claire M Khouri; Alison H Skalet; David Heiden; Gary N Holland; Todd P Margolis Journal: Am J Ophthalmol Date: 2012-01-20 Impact factor: 5.258
Authors: Somsanguan Ausayakhun; Alison H Skalet; Choeng Jirawison; Sakarin Ausayakhun; Jeremy D Keenan; Claire Khouri; Khang Nguyen; Partho S Kalyani; David Heiden; Gary N Holland; Todd P Margolis Journal: Am J Ophthalmol Date: 2011-09-08 Impact factor: 5.258
Authors: Michael Yen; Jenny Chen; Somsanguan Ausayakhun; Paradee Kunavisarut; Pornpattana Vichitvejpaisal; Sakarin Ausayakhun; Choeng Jirawison; Jessica Shantha; Gary N Holland; David Heiden; Todd P Margolis; Jeremy D Keenan Journal: Am J Ophthalmol Date: 2014-10-22 Impact factor: 5.258
Authors: Mark A Jacobson; Qi Xuan Tan; Valerie Girling; C Poon; Mark Van Natta; Douglas A Jabs; Margaret Inokuma; Holden T Maecker; Barry Bredt; Elizabeth Sinclair Journal: Clin Infect Dis Date: 2008-02-01 Impact factor: 9.079
Authors: Michael Yen; Somsanguan Ausayakhun; Jenny Chen; Sakarin Ausayakhun; Choeng Jirawison; David Heiden; Gary N Holland; Todd P Margolis; Jeremy D Keenan Journal: JAMA Ophthalmol Date: 2014-09 Impact factor: 7.389
Authors: Sophia Pathai; Clare Gilbert; Helen A Weiss; Matthew McNally; Stephen D Lawn Journal: Trop Med Int Health Date: 2011-01-05 Impact factor: 2.622
Authors: David Heiden; Nathan Ford; David Wilson; William R Rodriguez; Todd Margolis; Bart Janssens; Martha Bedelu; Nini Tun; Eric Goemaere; Peter Saranchuk; Kalpana Sabapathy; Frank Smithuis; Emmanuel Luyirika; W Lawrence Drew Journal: PLoS Med Date: 2007-12 Impact factor: 11.069